{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:51:23Z","timestamp":1791820283828,"version":"4.3.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","award":["IG-32238"],"award-info":[{"award-number":["IG-32238"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PNNR-D34Health","award":["PNC0000001"],"award-info":[{"award-number":["PNC0000001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Adeno-associated viral (AAV) vectors are widely used in gene therapy for their versatility and safety, but their broad tropism limits cell-specific applications such as targeting primary or metastatic tumor cells. To address this, we developed AAV-STITCH, a strategy using SpyTag technology to covalently attach polypeptides to the AAV capsid. This allows precise, dose-dependent coupling of an anti-GD2 scFv to a galactose-binding-deficient AAV9-W503A capsid, redirecting tropism specifically to GD2-expressing neuroblastoma (NB) cells. In pseudometastatic xenograft mouse models, AAV-STITCH\u03b1GD2 selectively transduced NB tumor cells without transduction of healthy liver tissue. Furthermore, delivery of a suicide gene via AAV-STITCH\u03b1GD2 significantly slowed tumor growth and extended survival in mice with subcutaneous and pseudometastatic NB xenografts. When combined with standard-of-care chemotherapy for relapsed NB, AAV-STITCH\u03b1GD2 produced robust curative effects. Collectively, these results demonstrate the feasibility of engineering AAVs with highly specific transduction properties, providing a versatile platform for targeted tumor cell suppression and advancing the development of next-generation, precision gene therapies for cancer.<\/jats:p>","DOI":"10.1038\/s44321-026-00520-7","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T18:09:25Z","timestamp":1789236565000},"page":"4117-4152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeted AAV gene therapy for neuroblastoma via direct capsid-antibody coupling"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5006-1827","authenticated-orcid":false,"given":"Mirko","family":"Luoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8227-271X","authenticated-orcid":false,"given":"Stefano","family":"Parracino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena G","family":"Giannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8770-1250","authenticated-orcid":false,"given":"Francesca","family":"Morosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostina","family":"Di Pizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7135-9780","authenticated-orcid":false,"given":"Sharon","family":"Muggeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Iannielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0015-9599","authenticated-orcid":false,"given":"Silvia","family":"Sicardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4589-9377","authenticated-orcid":false,"given":"Tamara","family":"Canu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ubaldo","family":"Del Carro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8312-808X","authenticated-orcid":false,"given":"Fabio","family":"Pastorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4050-0926","authenticated-orcid":false,"given":"Vania","family":"Broccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"key":"520_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41565-020-00785-0","volume":"16","author":"E Ambrosetti","year":"2021","unstructured":"Ambrosetti E, Bernardinelli G, Hoffecker I, Hartmanis L, Kiriako G, de Marco A, Sandberg R, Hogberg B, Teixeira AI (2021) A DNA-nanoassembly-based approach to map membrane protein nanoenvironments. Nat Nanotechnol 16:85\u201395","journal-title":"Nat Nanotechnol"},{"key":"520_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1021\/acssynbio.5c00565","volume":"15","author":"A Armbruster","year":"2026","unstructured":"Armbruster A, H\u00f6rner M, Wagner HJ, Fink-Straube C, Weber W (2026) Genetically encoded spytag enables modular AAV retargeting via SpyCatcher-fused ligands for targeted gene delivery. ACS Synth Biol 15:149\u2013160","journal-title":"ACS Synth Biol"},{"key":"520_CR47","doi-asserted-by":"crossref","unstructured":"Brignole C, Bensa V, Fonseca NA, Del Zotto G, Bruno S, Cruz AF, Malaguti F, Carlini B, Morandi F, Calarco E et al (2021) Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy. J Exp Clin Cancer Res 40:180","DOI":"10.1186\/s13046-021-01993-9"},{"key":"520_CR3","doi-asserted-by":"publisher","first-page":"e007174","DOI":"10.1136\/jitc-2023-007174","volume":"11","author":"C Brignole","year":"2023","unstructured":"Brignole C, Calarco E, Bensa V, Giusto E, Perri P, Ciampi E, Corrias MV, Astigiano S, Cilli M, Loo D et al (2023) Antitumor activity of the investigational B7-H3 antibody-drug conjugate, vobramitamab duocarmazine, in preclinical models of neuroblastoma. J Immunother Cancer 11:e007174","journal-title":"J Immunother Cancer"},{"key":"520_CR4","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1128\/CVI.05107-11","volume":"18","author":"R Calcedo","year":"2011","unstructured":"Calcedo R, Morizono H, Wang L, McCarter R, He J, Jones D, Batshaw M, Wilson JM (2011) Adeno-associated virus antibody profiles in newborns, children, and adolescents. Vaccin Immunol 18:1586\u20131588","journal-title":"Vaccin Immunol"},{"key":"520_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-04954-w","volume":"22","author":"M Capasso","year":"2024","unstructured":"Capasso M, Brignole C, Lasorsa VA, Bensa V, Cantalupo S, Sebastiani E, Quattrone A, Ciampi E, Avitabile M, Sementa AR et al (2024) From the identification of actionable molecular targets to the generation of faithful neuroblastoma patient-derived preclinical models. J Transl Med 22:151","journal-title":"J Transl Med"},{"key":"520_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd3438","volume":"13","author":"YK Chan","year":"2021","unstructured":"Chan YK, Wang SK, Chu CJ, Copland DA, Letizia AJ, Costa Verdera H, Chiang JJ, Sethi M, Wang MK, Neidermeyer WJ Jr et al (2021) Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses. Sci Transl Med 13:eabd3438","journal-title":"Sci Transl Med"},{"key":"520_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.omton.2025.201002","volume":"33","author":"C Chen","year":"2025","unstructured":"Chen C, Jiang Y, Feng C, Zhou Q, Luo X, Cai L, Zhao L (2025) Tumor-specific AAV delivery of interleukin-12 enhances antitumor immunity and safety in ovarian cancer xenograft mouse model. Mol Ther Oncol 33:201002","journal-title":"Mol Ther Oncol"},{"key":"520_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38582-7","volume":"14","author":"X Chen","year":"2023","unstructured":"Chen X, Wolfe DA, Bindu DS, Zhang M, Taskin N, Goertsen D, Shay TF, Sullivan EE, Huang S-F, Kumar SR et al (2023) Functional gene delivery to and across brain vasculature of systemic AAVs with endothelial-specific tropism in rodents and broad tropism in primates. Nat Commun 14:3345","journal-title":"Nat Commun"},{"key":"520_CR9","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/NEJMoa2210859","volume":"388","author":"F Del Bufalo","year":"2023","unstructured":"Del Bufalo F, De Angelis B, Caruana I, Del Baldo G, De Ioris MA, Serra A, Mastronuzzi A, Cefalo MG, Pagliara D, Amicucci M et al (2023) GD2-CART01 for relapsed or refractory high-risk neuroblastoma. N Engl J Med 388:1284\u20131295","journal-title":"N Engl J Med"},{"key":"520_CR10","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nrd.2018.110","volume":"17","author":"BE Deverman","year":"2018","unstructured":"Deverman BE, Ravina BM, Bankiewicz KS, Paul SM, Sah DWY (2018) Gene therapy for neurological disorders: progress and prospects. Nat Rev Drug Discov 17:641\u2013659","journal-title":"Nat Rev Drug Discov"},{"key":"520_CR11","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.260220","volume":"136","author":"A Di Pizio","year":"2023","unstructured":"Di Pizio A, Marvaldi L, Birling M-C, Okladnikov N, Dupuis L, Fainzilber M, Rishal I (2023) A conditional null allele of Dync1h1 enables targeted analyses of dynein roles in neuronal length sensing. J Cell Sci 136:jcs260220","journal-title":"J Cell Sci"},{"key":"520_CR48","doi-asserted-by":"crossref","unstructured":"Dondero A, Pastorino F, Della Chiesa M, Corrias MV, Morandi F, Pistoia V, Olive D, Bellora F, Locatelli F, Castellano A et al (2015) PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance. Oncoimmunology 5:e1064578","DOI":"10.1080\/2162402X.2015.1064578"},{"key":"520_CR49","doi-asserted-by":"crossref","unstructured":"Gargett T, Yu W, Dotti G, Yvon ES, Christo SN, Hayball JD, Lewis ID, Brenner MK, Brown MP (2016) GD2-specific CART Cells Undergo Potent Activation and Deletion Following Antigen Encounter but can be Protected From Activation-induced Cell Death by PD-1 Blockade. Mol Ther 24:1135\u20131149","DOI":"10.1038\/mt.2016.63"},{"key":"520_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109777","volume":"27","author":"SG Giannelli","year":"2024","unstructured":"Giannelli SG, Luoni M, Iannielli A, Middeldorp J, Philippens I, Bido S, Korbellin J, Broccoli V (2024) New AAV9 engineered variants with enhanced neurotropism and reduced liver off-targeting in mice and marmosets. iScience 27:109777","journal-title":"iScience"},{"key":"520_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fnana.2019.00093","volume":"13","author":"L Haery","year":"2019","unstructured":"Haery L, Deverman BE, Matho KS, Cetin A, Woodard K, Cepko C, Guerin KI, Rego MA, Ersing I, Bacle SM et al (2019) Adeno-associated virus technologies and methods for targeted neuronal manipulation. Front Neuroanat 13:93","journal-title":"Front Neuroanat"},{"key":"520_CR14","doi-asserted-by":"publisher","first-page":"e3001958","DOI":"10.1371\/journal.pbio.3001958","volume":"21","author":"H Hao","year":"2023","unstructured":"Hao H, Ramli R, Wang C, Liu C, Shah S, Mullen P, Lall V, Jones F, Shao J, Zhang H et al (2023) Dorsal root ganglia control nociceptive input to the central nervous system. PLoS Biol 21:e3001958","journal-title":"PLoS Biol"},{"key":"520_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.omto.2022.03.009","volume":"25","author":"LA Kankeu Fonkoua","year":"2022","unstructured":"Kankeu Fonkoua LA, Sirpilla O, Sakemura R, Siegler E, Kenderian S (2022) CAR T cell therapy and the tumor microenvironment: current challenges and opportunities. Mol Ther Oncolytics 25:69\u201377","journal-title":"Mol Ther Oncolytics"},{"key":"520_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-21742-x","volume":"8","author":"D Katrekar","year":"2018","unstructured":"Katrekar D, Moreno AM, Chen G, Worlikar A, Mali P (2018) Oligonucleotide conjugated multi-functional adeno-associated viruses. Sci Rep 8:3589","journal-title":"Sci Rep"},{"key":"520_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/978-1-4939-7574-7_20","volume":"1728","author":"RE Kelemen","year":"2018","unstructured":"Kelemen RE, Erickson SB, Chatterjee A (2018) Production and chemoselective modification of adeno-associated virus site-specifically incorporating an unnatural amino acid residue into its capsid. Methods Mol Biol 1728:313\u2013326","journal-title":"Methods Mol Biol"},{"key":"520_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-05841-4","volume":"12","author":"A Kinkhabwala","year":"2022","unstructured":"Kinkhabwala A, Herbel C, Pankratz J, Yushchenko DA, Ruberg S, Praveen P, Reiss S, Rodriguez FC, Sch\u00e4fer D, Kollet J et al (2022) MACSima imaging cyclic staining (MICS) technology reveals combinatorial target pairs for CAR T cell treatment of solid tumors. Sci Rep 12:1911","journal-title":"Sci Rep"},{"key":"520_CR19","first-page":"909","volume":"3","author":"G Lammie","year":"1993","unstructured":"Lammie G, Cheung N, Gerald W, Rosenblum M, Cordoncardo C (1993) Ganglioside gd(2) expression in the human nervous-system and in neuroblastomas\u2014an immunohistochemical study. Int J Oncol 3:909\u2013915","journal-title":"Int J Oncol"},{"key":"520_CR20","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-020-0911-7","volume":"26","author":"C Leborgne","year":"2020","unstructured":"Leborgne C, Barbon E, Alexander JM, Hanby H, Delignat S, Cohen DM, Collaud F, Muraleetharan S, Lupo D, Silverberg J et al (2020) IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies. Nat Med 26:1096\u20131101","journal-title":"Nat Med"},{"key":"520_CR21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jneuroim.2005.03.025","volume":"170","author":"S Marconi","year":"2005","unstructured":"Marconi S, De Toni L, Lovato L, Tedeschi E, Gaetti L, Acler M, Bonetti B (2005) Expression of gangliosides on glial and neuronal cells in normal and pathological adult human brain. J Neuroimmunol 170:115\u2013121","journal-title":"J Neuroimmunol"},{"key":"520_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.78","volume":"2","author":"KK Matthay","year":"2016","unstructured":"Matthay KK, Maris JM, Schleiermacher G, Nakagawara A, Mackll CL, Diller L, Weiss WA (2016) Neuroblastoma. Nat Rev Dis Prim 2:16078","journal-title":"Nat Rev Dis Prim"},{"key":"520_CR23","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1038\/mt.2008.171","volume":"16","author":"DM McCarty","year":"2008","unstructured":"McCarty DM (2008) Self-complementary AAV vectors; advances and applications. Mol Ther 16:1648\u20131656","journal-title":"Mol Ther"},{"key":"520_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06621-3","volume":"9","author":"A Meliani","year":"2018","unstructured":"Meliani A, Boisgerault F, Hardet R, Marmier S, Collaud F, Ronzitti G, Leborgne C, Costa Verdera H, Sola MS, Charles S et al (2018) Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration. Nat Commun 9:4098","journal-title":"Nat Commun"},{"key":"520_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59088-4","volume":"16","author":"M Mietzsch","year":"2025","unstructured":"Mietzsch M, His J, Nelson AR, Khandekar N, Huang A-M, Smith N, Jc, Zachary J, Potts L, Farrar MA, Cipman P et al (2025) Structural characterization of antibody-responses following Zolgensma treatment for AAV capsid engineering to expand patient cohorts. Nat Commun 16:3731","journal-title":"Nat Commun"},{"key":"520_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1380917","volume":"14","author":"J Mora","year":"2024","unstructured":"Mora J, Climent A, Roldan M, Flores MC, Varo A, Perez-Jaume S, Jou C, Celma MS, Lazaro JJ, Cheung I et al (2024) Desensitizing the autonomic nervous system to mitigate anti-GD2 monoclonal antibody side effects. Front Oncol 14:1380917","journal-title":"Front Oncol"},{"key":"520_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/mt.2012.186","volume":"21","author":"RC M\u00fcnch","year":"2013","unstructured":"M\u00fcnch RC, Janicki H, V\u00f6lker I, Rasbach A, Hallek M, B\u00fcning H, Buchholz CJ (2013) Displaying high-affinity ligands on adeno-associated viral vectors enables tumor cell-specific and safe gene transfer. Mol Ther 21:109\u2013118","journal-title":"Mol Ther"},{"key":"520_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7246","volume":"6","author":"RC M\u00fcnch","year":"2015","unstructured":"M\u00fcnch RC, Muth A, Muik A, Friedel T, Schmatz J, Dreier B, Trkola A, Pl\u00fcckthun A, B\u00fcning H, Buchholz C (2015) Off-target-free gene delivery by affinity-purified receptor-targeted viral vectors. Nat Commun 6:6246","journal-title":"Nat Commun"},{"key":"520_CR29","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.chom.2011.10.014","volume":"10","author":"M Nonnenmacher","year":"2011","unstructured":"Nonnenmacher M, Weber T (2011) Adeno-associated virus 2 infection requires endocytosis through the CLIC\/GEEC pathway. Cell Host Microbe 10:563\u2013576","journal-title":"Cell Host Microbe"},{"key":"520_CR30","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.omtm.2022.07.001","volume":"26","author":"T Oishi","year":"2022","unstructured":"Oishi T, Ito M, Koizumi M, Yamamoto T, Yamagishi S, Yamasaki T, Sameshima T, Suzuki T, Sugimura H et al (2022) Efficacy of HSV-TK\/GCV system suicide gene therapy using SHED expressing modified HSV-TK against lung cancer brain metastases. Mol Ther Methods Clin Dev 26:253\u2013265","journal-title":"Mol Ther Methods Clin Dev"},{"key":"520_CR50","doi-asserted-by":"crossref","unstructured":"Paret C, Wingerter A, Seidmann L, Ustjanzew A, Sathyamurthy S, Ludwig J, Schwickerath P, Brignole C, Pastorino F, Wagner S et al (2025) Ganglioside Profiling Uncovers Distinct Patterns in High-Risk Neuroblastoma. Int J Mol Sci 26:8431","DOI":"10.3390\/ijms26178431"},{"key":"520_CR31","doi-asserted-by":"publisher","first-page":"4809","DOI":"10.1158\/1078-0432.CCR-10-1354","volume":"16","author":"F Pastorino","year":"2010","unstructured":"Pastorino F, Loi M, Sapra P, Becherini P, Cilli M, Emionite L, Ribatti D, Greenberg LM, Horak ID, Ponzoni M (2010) Tumor regression and curability of preclinical neuroblastoma models by PEGylated SN38 (EZN-2208), a novel topoisomerase I inhibitor. Clin Cancer Res 16:4809\u20134821","journal-title":"Clin Cancer Res"},{"key":"520_CR51","doi-asserted-by":"crossref","unstructured":"Potter RA, Peterson EL, Griffin D, Cooper Olson G, Lewis S, Cochran K, Mendell JR, Rodino-Klapac LR (2024) Use of plasmapheresis to lower anti-AAV antibodies in nonhuman primates with pre-existing immunity to AAVrh74. Mol Ther Methods Clin Dev 32:101195","DOI":"10.1016\/j.omtm.2024.101195"},{"key":"520_CR32","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/nm.1882","volume":"14","author":"MA Pule","year":"2008","unstructured":"Pule MA, Savoldo B, Myers GD, Rossig C, Russell HV, Dotti G, Huls MH, Liu E, Gee AP, Mei Z et al (2008) Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence activity in individuals with neuroblastoma. Nat Med 14:1264\u20131270","journal-title":"Nat Med"},{"key":"520_CR33","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.omtn.2023.01.007","volume":"31","author":"F Puzzo","year":"2023","unstructured":"Puzzo F, Zhang C, Powell Gray B, Zhang F, Sullenger BA, Kay MA (2023) Aptamer-programmable adeno-associated viral vectors as a novel platform for cell-specific gene transfer. Mol Ther Nucleic Acids 31:383\u2013397","journal-title":"Mol Ther Nucleic Acids"},{"key":"520_CR34","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41571-022-00643-z","volume":"19","author":"B Qiu","year":"2022","unstructured":"Qiu B, Matthay KK (2022) Advancing therapy for neuroblastoma. Nat Rev Clin Oncol 19:515\u2013533","journal-title":"Nat Rev Clin Oncol"},{"key":"520_CR35","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1016\/j.ejca.2010.05.004","volume":"46","author":"H Rubie","year":"2010","unstructured":"Rubie H, Geoerger B, Frappaz D, Schmitt A, Leblond P, Ndiaye A, Aerts I, Le Deley M-C, Gentet J-C, Paci A et al (2010) Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumours. Eur J Cancer 46:2763\u20132770","journal-title":"Eur J Cancer"},{"key":"520_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/srep37540","volume":"6","author":"A Rubio","year":"2016","unstructured":"Rubio A, Luoni M, Giannelli SG, Radice I, Iannielli A, Cancellieri C, Di Berardino C, Regalia G, Lazari G, Menegon A et al (2016) Rapid and efficient CRISPR\/Cas9 gene inactivation in human neurons during human pluripotent stem cell differentiation and direct reprogramming. Sci Rep 6:37540","journal-title":"Sci Rep"},{"key":"520_CR37","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1016\/j.ymthe.2024.05.004","volume":"32","author":"TJ Smith","year":"2024","unstructured":"Smith TJ, Elmore ZC, Fusco RM, Hull JA, Rosales A, Martinez M, Tarantal AF, Asokan A (2024) Engineered IgM and IgG cleaving enzymes for mitigating antibody neutralization and complement activation in AAV gene transfer. Mol Ther 32:2080\u20132093","journal-title":"Mol Ther"},{"key":"520_CR38","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd6169","volume":"12","author":"K Straathof","year":"2020","unstructured":"Straathof K, Flutter B, Wallace R, Jain N, Loka T, Depani S, Wright G, Thomas S, Cheung GW-K, Gileadi T et al (2020) Antitumor activity without on-target off-tumor toxicity of GD2-chimeric antigen receptor T cells in patients with neuroblastoma. Sci Transl Med 12:eabd6169","journal-title":"Sci Transl Med"},{"key":"520_CR39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-022-00579-0","volume":"22","author":"SM Swain","year":"2023","unstructured":"Swain SM, Shastry M, Hamilton E (2023) Targeting HER2-positive breast cancer: advances and future directions. Nat Rev Drug Discov 22:101\u2013126","journal-title":"Nat Rev Drug Discov"},{"key":"520_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33225-0","volume":"8","author":"SJ Tobin","year":"2018","unstructured":"Tobin SJ, Wakefield DL, Jones V, Liu X, Schmolze D, Jovanovi\u0107-Talisman T (2018) Single molecule localization microscopy coupled with touch preparation for the quantification of trastuzumab-bound HER2. Sci Rep 8:15154","journal-title":"Sci Rep"},{"key":"520_CR41","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1111\/cas.15843","volume":"114","author":"S Umegaki","year":"2023","unstructured":"Umegaki S, Shirota H, Kasahara Y, Iwasaki T, Ishioka C (2023) Distinct role of CD8 cells and CD4 cells in antitumor immunity triggered by cell apoptosis using a Herpes simplex virus thymidine kinase\/ganciclovir system. Cancer Sci 114:3076\u20133086","journal-title":"Cancer Sci"},{"key":"520_CR52","doi-asserted-by":"crossref","unstructured":"Veggiani G, Nakamura T, Brenner MD, Gayet RV, Yan J, Robinson CV, Howarth M (2016) Programmable polyproteams built using twin peptide superglues. Proc Natl Acad Sci USA 113:1202\u20131207","DOI":"10.1073\/pnas.1519214113"},{"key":"520_CR42","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3389\/fendo.2019.00782","volume":"10","author":"V Veschi","year":"2019","unstructured":"Veschi V, Verona F, Thiele CJ (2019) Cancer stem cells and neuroblastoma: characteristics and therapeutic targeting options. Front Endocrinol 10:782","journal-title":"Front Endocrinol"},{"key":"520_CR43","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1593\/neo.04310","volume":"6","author":"JD Walton","year":"2004","unstructured":"Walton JD, Kattan DR, Thomas SK, Spengler BA, Guo HF, Biedler JL, Cheung NK, Ross RA (2004) Characteristics of stem cells from human neuroblastoma cell lines and in tumors. Neoplasia 6:838\u2013845","journal-title":"Neoplasia"},{"key":"520_CR44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","volume":"9","author":"JH Wang","year":"2024","unstructured":"Wang JH, Gessler DJ, Zhan W, Gallagher TL, Gao G (2024) Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal Transduct Target Ther 9:78","journal-title":"Signal Transduct Target Ther"},{"key":"520_CR45","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1056\/NEJMoa0911123","volume":"363","author":"AL Yu","year":"2010","unstructured":"Yu AL, Gilman AL, Ozkaynak MF, London WB, Kreissman SG, Chen HX, Smith M, Anderson B, Villablanca JG, Matthay KK et al (2010) Anti GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med 363:1324\u20131334","journal-title":"N Engl J Med"},{"key":"520_CR46","doi-asserted-by":"publisher","first-page":"e690","DOI":"10.1073\/pnas.1115485109","volume":"109","author":"B Zakeri","year":"2012","unstructured":"Zakeri B, Fierer JO, Celik E, Chittock EC, Schwarz-Linek U, Moy VT, Howarth M (2012) Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin. Proc Natl Acad Sci USA 109:e690\u2013e697","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00520-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00520-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00520-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:42:02Z","timestamp":1791819722000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-026-00520-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":52,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,12]]}},"alternative-id":["520"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00520-7","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,12]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LM, SP and VB are inventors of filed patents based on the work published here. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}